PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21924076-0	2011	[Effect of atorvastatin on advanced glycation end products induced monocyte chemoattractant protein-1 expression in cultured human endothelial cells].	Atorvastatin	11-23	C-C motif chemokine ligand 2	Homo sapiens	67-101	
21924076-1	2011	OBJECTIVE: To investigate the effects of atorvastatin on advanced glycation end products (AGE) induced monocyte chemoattractant protein-1 (MCP-1) expression in human umbilical vein endothelial cells (HUVECs) and whether this effect could be linked to peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and nuclear factor-kappaB (NF-kappaB).	Atorvastatin	41-53	C-C motif chemokine ligand 2	Homo sapiens	103-137	
21924076-1	2011	OBJECTIVE: To investigate the effects of atorvastatin on advanced glycation end products (AGE) induced monocyte chemoattractant protein-1 (MCP-1) expression in human umbilical vein endothelial cells (HUVECs) and whether this effect could be linked to peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and nuclear factor-kappaB (NF-kappaB).	Atorvastatin	41-53	C-C motif chemokine ligand 2	Homo sapiens	139-144	
21924076-4	2011	RESULTS: (1) The expression of MCP-1 mRNA was increased in proportion with increasing concentrations of AGEs which could be blocked by atorvastatin in a dose-dependent manner.	Atorvastatin	135-147	C-C motif chemokine ligand 2	Homo sapiens	31-36	
21924076-7	2011	(4) PPAR-gamma inhibitor antagonized the effect of atorvastatin on the expression of phospho-NF-kappaB p65 protein, nonphospho-NF-kappaB p65 protein and MCP-1 mRNA stimulated by AGE in HUVECs (P < 0.01).	Atorvastatin	51-63	C-C motif chemokine ligand 2	Homo sapiens	153-158